43 related articles for article (PubMed ID: 15580407)
1. Non-celiac Enteropathy and Olmesartan: An Essential Consideration.
Doukas SG; Doukas PG; Velpari S
Cureus; 2024 Feb; 16(2):e54373. PubMed ID: 38505463
[TBL] [Abstract][Full Text] [Related]
2. Celiac disease, enteropathy-associated T-cell lymphoma, and primary sclerosing cholangitis in one patient: a very rare association and review of the literature.
Majid N; Bernoussi Z; Mrabti H; Errihani H
Case Rep Oncol Med; 2013; 2013():838941. PubMed ID: 24381773
[TBL] [Abstract][Full Text] [Related]
3. Pancreatoduodenectomy for monomorphic epitheliotropic intestinal T-cell lymphoma with duodenal obstruction.
Olecki EJ; Rakszawski KL; Peng JS
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35318206
[TBL] [Abstract][Full Text] [Related]
4. Possible relationship between refractory celiac disease and malignancies.
Demiroren K
World J Clin Oncol; 2022 Mar; 13(3):200-208. PubMed ID: 35433292
[TBL] [Abstract][Full Text] [Related]
5. Primary duodenal papilla lymphoma producing obstructive jaundice: a case report.
Wang J; Han J; Xu H; Tai S; Xie X
BMC Surg; 2022 Mar; 22(1):110. PubMed ID: 35321694
[TBL] [Abstract][Full Text] [Related]
6. The Liver and Celiac Disease.
Rubio-Tapia A; Murray JA
Clin Liver Dis; 2019 May; 23(2):167-176. PubMed ID: 30947869
[TBL] [Abstract][Full Text] [Related]
7. Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges.
Gentille C; Qin Q; Barbieri A; Ravi PS; Iyer S
Ecancermedicalscience; 2017; 11():771. PubMed ID: 29062389
[TBL] [Abstract][Full Text] [Related]
8. Liver involvement in celiac disease.
Rubio-Tapia A; Murray JA
Minerva Med; 2008 Dec; 99(6):595-604. PubMed ID: 19034257
[TBL] [Abstract][Full Text] [Related]
9. Biliary tract obstruction secondary to malignant lymphoma: experience at a referral center.
Odemiş B; Parlak E; Başar O; Yüksel O; Sahin B
Dig Dis Sci; 2007 Sep; 52(9):2323-32. PubMed ID: 17406815
[TBL] [Abstract][Full Text] [Related]
10. Celiac disease.
Leffler D; Saha S; Farrell RJ
Am J Manag Care; 2003 Dec; 9(12):825-31; quiz 832-3. PubMed ID: 14712759
[TBL] [Abstract][Full Text] [Related]
11. Jaundice caused by a clinically undetectable T-cell lymphoma infiltrating the sphincter of Oddi.
Weinstock LB; Swanson PE; Bennett KJ; Van Amburg A; Wald SM; Shah NB
Am J Gastroenterol; 2001 Nov; 96(11):3186-9. PubMed ID: 11721770
[TBL] [Abstract][Full Text] [Related]
12. Obstructive jaundice caused by enteropathy-associated T-cell lymphoma in a patient with celiac sprue.
Buess M; Steuerwald M; Wegmann W; Rothen M
J Gastroenterol; 2004 Nov; 39(11):1110-3. PubMed ID: 15580407
[TBL] [Abstract][Full Text] [Related]
13. [Complication associated with celiac disease].
Baños Madrid R; Mercader Martínez J; Sánchez Bueno F; Bas Bernal A
An Med Interna; 2002 Feb; 19(2):81-4. PubMed ID: 11989104
[TBL] [Abstract][Full Text] [Related]
14. Primary duodenal lymphoma producing obstructive jaundice.
Bandyopadhyay SK; Moulick A; Dutta A
J Assoc Physicians India; 2007 Jan; 55():76-7. PubMed ID: 17444348
[TBL] [Abstract][Full Text] [Related]
15. [Polyradiculopathy revealing an enteropathy associated T-cell lymphoma in a patient with celiac disease].
Jousserand G; Poujois A; Antoine JC; Camdessanché JP
Rev Neurol (Paris); 2009 Jan; 165(1):89-91. PubMed ID: 18808770
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
